CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenue
Housing	$ 0	$ 142,423
Commercial rental	0	0
Tissue array products	151,152	99,910
Total revenue	151,152	242,333
Cost of Sales
Housing	0	123,499
Commercial rental - related party	16,696	16,466
Tissue array products	98,520	79,314
Total cost of sales	115,216	219,279
Gross Profit	35,936	23,054
Operating Expenses:
Salaries and wages	53,913	52,244
Depreciation and amortization	33,445	38,447
Bad debt expense	6,630	0
Estimates of loss contingencies	0	16,229
Professional fees	40,107	1,379
Selling and distribution expenses	4,186	30,342
Other general and administrative expenses	27,592	18,710
Total Operating Expenses	165,873	157,351
Loss from Operations	(129,937)	(134,297)
Other Income (Expense)
Interest expenses, net	(46,188)	(45,990)
Other expense, net	(2,048)	(26,057)
Total Other Expense, Net	(48,236)	(72,047)
Loss before Income Taxes	(178,173)	(206,344)
Income Tax Expense	142	0
Net loss	(178,315)	(206,344)
Less: Net loss attributable to the non-controlling interests	(31,493)	(38,465)
Net loss attributable to CYBRDI, INC.	(146,822)	(167,879)
Foreign currency translation loss	(37,094)	(3,860)
Comprehensive loss	$ (183,916)	$ (171,739)
Net Loss Per Common Share
Basic and Diluted	$ 0.00	$ 0.00
Weighted Average Number of Shares Outstanding
Basic and Diluted	120,225,323	120,225,323